Narumi Satoshi, Fox Larry A, Fukudome Keisuke, Sakaguchi Zenichi, Sugisawa Chiho, Abe Kiyomi, Kameyama Kaori, Hasegawa Tomonobu
Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Division of Endocrinology, Nemours Children's Specialty Care, Jacksonville, FL 32207, USA.
Endocr J. 2017 Nov 29;64(11):1087-1097. doi: 10.1507/endocrj.EJ17-0194. Epub 2017 Sep 1.
Thyroid peroxidase (TPO) deficiency, caused by biallelic TPO mutations, is a well-established genetic form of congenital hypothyroidism (CH). More than 100 patients have been published, and the patients have been diagnosed mostly in the frame of newborn screening (NBS) programs. Correlation between clinical phenotypes and TPO activity remains unclear. Here, we report clinical and molecular findings of two unrelated TPO mutation-carrying mildly hypothyroid patients. The two patients were born at term after an uneventful pregnancy and delivery, and were NBS negative. They sought medical attention due to goiter at age 8 years. Evaluation of the thyroid showed mild elevation of serum TSH levels, normal or slightly low serum T levels, high serum T to T molar ratio, high serum thyroglobulin levels, and high thyroidal I uptake. We performed next-generation sequencing-based genetic screening, and found that one patient was compound heterozygous for two novel TPO mutations (p.Asp224del; c.820-2A>G), and the other was homozygous for a previously known mutation (p.Trp527Cys). In vitro functional analyses using HEK293 cells showed that the two amino acid-altering mutations (p.Asp224del and p.Trp527Cys) caused partial loss of the enzymatic activity. In conclusion, we report that TPO mutations with residual activity are associated with mild TPO deficiency, which is clinically characterized by marked goiter, mild TSH elevation, high serum T to T molar ratio, and high serum thyroglobulin levels. Our findings illuminate the hitherto under-recognized correlation between clinical phenotypes and residual enzymatic activity among patients with TPO deficiency.
由双等位基因 TPO 突变引起的甲状腺过氧化物酶(TPO)缺乏是一种公认的先天性甲状腺功能减退症(CH)的遗传形式。已发表了 100 多名患者的相关报道,这些患者大多是在新生儿筛查(NBS)项目中被诊断出来的。临床表型与 TPO 活性之间的相关性仍不清楚。在此,我们报告了两名携带 TPO 突变的非亲缘关系的轻度甲状腺功能减退患者的临床和分子学发现。这两名患者足月出生,孕期和分娩过程均正常,新生儿筛查结果为阴性。他们因 8 岁时出现甲状腺肿大而就医。甲状腺评估显示血清促甲状腺激素(TSH)水平轻度升高,血清总甲状腺素(T)水平正常或略低,血清 T 与 T 的摩尔比升高,血清甲状腺球蛋白水平升高,甲状腺碘摄取率升高。我们进行了基于二代测序的基因筛查,发现一名患者为两个新的 TPO 突变(p.Asp224del;c.820 - 2A>G)的复合杂合子,另一名患者为一个已知突变(p.Trp527Cys)的纯合子。使用 HEK293 细胞进行的体外功能分析表明,这两个氨基酸改变突变(p.Asp224del 和 p.Trp527Cys)导致酶活性部分丧失。总之,我们报告具有残余活性的 TPO 突变与轻度 TPO 缺乏有关,其临床特征为明显的甲状腺肿大、轻度 TSH 升高、血清 T 与 T 的摩尔比升高以及血清甲状腺球蛋白水平升高。我们的发现揭示了 TPO 缺乏患者临床表型与残余酶活性之间迄今未被充分认识的相关性。